News & Insights
Media Contact: pr@oerthbio.com
Oerth Bio celebrates the opening of our new R&D facility »
How PROTAC® technology works »
Bayer highlights promise of protein degraders for AG »
World Agri-Tech Innovation Summit: 9 Minutes with John Dombrosky »
Revolutionizing Agriculture for good »
John Dombrosky at Bayer Innovation Forum »
Meet Oerth Bio »
Press Releases
-
May 5, 2023Oerth Bio receives Triangle Business Journal’s 2023 Life Sciences Award
-
March 15, 2023Oerth Bio Among Top 50 AgTech and FoodTech Innovators in 2023 THRIVE Report
-
March 9, 2023Oerth Bio Accelerates Operations, Launches Research Collaboration with North Carolina Plant Sciences Initiative
-
January 19, 2023Bayer launches new collaboration with Oerth Bio to further advance innovations in crop protection
-
November 15, 2022Yara International and Oerth Bio collaborate to tackle crop resilience
-
January 18, 2022Oerth Bio Expands Board of Directors with Appointment of Veteran Biotech Company Builder and Investor Thong Q. Le
-
August 26, 2021Oerth Bio Announces Strategic Additions to Leadership Team
-
October 1, 2019Bayer and Arvinas Unveil Targeted Protein Degradation Joint Venture, Oerth Bio
-
June 4, 2019Bayer and Arvinas to Collaborate on Human PROTAC Therapies and Launch a Separate Joint Venture to Develop Agricultural PROTAC Applications
Industry News
-
June 15, 2021Advancing targeted protein degradation for cancer therapy -
May 7, 2021PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy -
April 17, 2019Targeted protein degradation: elements of PROTAC design -
April 30, 2018Targeted Protein Degradation: Unlocking the Therapeutic Proteome
The team behind the tech
Great companies have great people and strong cultures. Get to know ours.
Meet Our Team